health corp expert
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ALRT could be a good one. Healthcare technology and FDA cleared. Just waiting for news of a contract. Diabetes patient management.
ALRT could be the hottest of all soon. Everything in place.FDA clearnce, HIPAA secuity. Just waiting on contract to be announced. Diabetes management technology. Only .04 as of today
Why aren't there lots of buyers at this crazy low price--has to be that no one knows about this stock or they don't understand the changes coming in healthcare. Wish I had extra cash. Could pick up several hundred thousand shares at next to nothing.
HIPAA security finalized for ALRT. This should be the final step for them to go live in market..FDA clearance a year ago. Price had dropped down to .04 now. Great buying opportunity I would expect although it appears no one knows about this stock, ALRT.
Janet, bid is low because there are clearly no buyers who see the big upside. If there were, they would be scooping up all that's available at this incredibly low price. I'm hope to convert some other assets to raise cash and start buying but it's taking me a little time to do so. Once the commercial viability is shown, i.e., some contracts/deals, the volume could/should reach an average of 500,000 more daily. And the speed of price increase will depend on the magnitude of the first contract or deal.
yeah, noticed that as well. Very thin on the ASK side as well. If someone came in and hit the ASK for about 100,000 shares in short order at market price, the price could go up to $0.35 today. Which is where it should be given the fundamental development progress of their system. And once they announce contracts, it appears that for every 100,000 diabetes patients on the system could represent a $1 to $2 stock price. I'm waiting on 1 million patients and a $20 price. Go ALRT!
I think buyout offers are a certainty once they prove commercial viability. They have FDA clearance and universal capability. And I'm personally positive that the big insurance groups will want their system, thus big players such as a Medtronics or GE Healthcare, etc. or a large PBM such as a Medco or Caremark can see the long term revenue and profit from acquiring ALRT. Or some of the large Diabetes Care companies.
Janet, I doubt that most shareholders have any idea that good news may come out soon. ALRT hasn't posted any news for so long that shareholders could be giving up. Most don't read these investor comment boards.
the "new" healthcare should be good for ALRT. All insurance providers will be looking for significant cost reduction programs and for programs that improve their health outcome performance. ALRT system can do all these. Now that the election is over, health groups can begin making decisions.
until news of commercial startup it will likely remain thin. After that the buyers should be entering and demand will start surging the price upward.
Maybe some more good news. This came out on Thursday of last week.
Very interesting; this could move the suppliers to ALRT and the HeC. According to ALRT news stories over the past year, this is one of their targeted areas but I don't think it's their primary revenue area.
The site where this appeared is http://www.cgsmedicare.com/jc/pubs/news/2012/1012/cope20351.html but here below is the information
November 1, 2012
Consumable Supplies - Request for Refill Documentation Requirements
The Durable Medical Equipment Medicare Administrative Contractors have been conducting reviews on claims for consumable supplies. One of the top reasons for denials has been request for refill documentation. The most common errors involve how suppliers are documenting the quantity of an item the beneficiary has remaining.
For consumable supplies, i.e. those that are used up (e.g., ostomy, urological supplies, surgical dressings, or glucose supplies etc.) the supplier must sufficiently assess the quantity of each item that the beneficiary still has on hand, to determine that the amount remaining will be nearly exhausted. The following are some examples (not all-inclusive) of documentation that is not sufficient to justify reimbursement:
• "Yes" or "No" questions only regarding whether the beneficiary wants or needs more supplies.
• Documentation which only provides information regarding the amount of supplies the beneficiary is requesting.
• Documentation which only states that the beneficiary has less than the required threshold number of supplies left, e.g., Mrs. J stated that she has less than 14 days of glucose strips left.
Vague or nonspecific references to the quantity remaining are not sufficient to demonstrate compliance with the requirement that refills be provided when the current supply on hand is "approaching exhaustion". There must be an individualized and detailed record that quantifies the beneficiary’s remaining supplies. An actual count is recommended but not necessary, but the record should evidence that an individual assessment has been performed. Note that a quantitative or semi-quantitative assessment actually performed individually for each refill would not have identical language in the record for each subsequent refill for the same beneficiary. Likewise, identical language for different beneficiaries would raise suspicions about whether individual assessments were actually performed.
There must be sufficient, specific and credible information regarding the quantity the beneficiary still has remaining for the reviewer to be able to determine that the quantity was actually assessed and will be approaching exhaustion on the delivery date, as required by CMS, Program Integrity Manual, Chapter 5, section 5.2.6.
For more information regarding these items and their requirements, refer to the local coverage determination and policy articles, supplier manual, and the standard documentation language articles.
Janet.Great to hear!. I'd say just wait til they put out a news release on their progress. Yes, I'm in for the long haul. I see their system as becoming standard in diabetes patient care. So much good it can bring to patients health and to health plan cost reduction. We're looking at a multi billion $ market and hopefully ALRT will become the leader.
Janet, did you hear anything back. Actually in looking over their past news releases, it was only about two months ago (Aug.28) they announced completion of the development phase of their system so two months is not very long. More patience, I'm now thinking it could be mid November or at least before Christmas that we hear about something big from them.
5 different market makers have sell orders under .07 Absolutely crazy stuff.
I'm sure their phone number is on web site. email is contact@alrt.com I believe.
News on a business contract will change it all quickly though. One announced deal and we could see huge increases quickly.
agreed Janet, this is absolutely nuts. But, with maybe hundreds or thousands of shareholders, they are always some who give up on a stock and sell----especially when there has been no news on business developement in months.
Janet, could be some of the shareholders who have been in for 8 to 10 years or longer and have lost their patience. I agree with Lone, and the points he brought up in his last post about the news release that referred to end of 3rd Quarter to finalize some security or quality control due to HIPAA requirements. We're now just past third quarter so an update or notice of business agreements could be soon....assuming they accomplished what they stated in the 3rd Q.
strange stuff. And the bid is down to .04. totally nuts. No one knows about this company and some shareholders clearly have lost confidence. We need news of a healthcare company contract asap. Where is the news?
Janet, then you'll retire even sooner.......they should gain several large health plans if their system does what the press says it will
based on financial data and net cash flow they presented in the Webinar they held a few months bac,it appears it takes only about 100,000 diabetes patients to equate to a stock value around $2 per share---assuming I understood their numbers correctly--and assuming a p/e of 20 or so. Just one medium size health plan should bring in that many diabetes patients.And how could a health plan decide NOT to use their system? Better health outcome along with reduction in costs. Wow!!
Sounds great didirocks!!! Is the start this week or next week? Big corporation signing on right away? Let it Rock!!
Agree with you. ARNA will win out due to better safety profile and the EU advantage. I'm big supporter of ARNA and a small cap with symbol ALRT. ALRT is primed to go, same as ARNA. Healthcare related but they are healthcare technology.....very unique platform.
JanetJ; yes I did. I view it as here is a company with management and family willing to continue to spend $3 million or so a year to keep this company going forward, new board members, development progress, and as such it shows me their confidence in success. It also suggests they have it together and we could very well see the market place contracts soon. No one would continue to pump their own money(at these substantial levels) into a platform/system unless they had some good reason to know the market wants it and will soon be paying for it. My opinion.
well for sure it's time for some news on market development--contracts with some big companies. Been a long wait----so it should happen any time now. Yes, many frustrated shareholders but maybe just a bit more patience and all will be smiling/celebrating. Such a good product they have. Improve health outcome AND lower costs of care. Perfect.
JanetJackson; I would guess that since the bid is so low today and the ASK is .072, that you could pick up 40,000 shares with a bid of .07.....if that's what you're planning on. I hope you get it bought, then the news starts hitting.
your bid must have not been high enough, otherwise a seller would have hit the bid. Bids below .07 likely won't be picked up at least not lately. Sellers appear to no longer willing to sell that low.
Great news for ALRT. Check out the news in most newspapers today about $750 billion in healthcare waste and abuse. The ALRT HeC system is perfect for waste and abuse in the diabetes glucose testing market. This should help speed up the process. The following was information on this very subject from the CEO of ALRT in a news release earlier this year. “There are many reasons that diabetes is so costly, including disease prevalence, poor patient adherence, and lack of accountability around blood glucose self-testing supplies covered by both public and private payers,” added Sidney S. Chan, Chairman and Chief Executive Officer at ALR Technologies. “Recent reports from the U.S. Department of Health and Human Services, Office of Inspector General (available to the public at http://oig.hhs.gov), indicate the loss of nearly $218 million annually from the Medicare program attributed to poor documentation around self-testing supplies. These statistics do not account for losses incurred by Medicaid or private payers. Improving accountability around diabetes self-glucose testing supplies alone could save the U.S. healthcare delivery system billions of dollars over the next five years.”
Mr. Chan continued, “A recent study from the Temple University School of Pharmacy indicates that the U.S. could save up to $8.1 billion annually by improving patient adherence to diabetes treatment plans. Currently, there is very little oversight around the buying, selling and appropriate use of diabetes self-glucose testing supplies. Attempts at oversight are fragmented, primarily paper-based, and rely on unverifiable patient reporting. Our HeC system provides solutions to overcome these obstacles and potentially save the country billions of dollars while providing better healthcare for its citizens. We feel that the timing could not be better for our company and shareholders as we are emerging as a leader in the chronic disease management space.”
I concur with you janetjackson. Appears they are getting everything in order in time for the BIG NEWs we all expect to hear soon. Maybe reach that $2 for NASDAQ soon???
Not sure, but I think that a company can upgrade to NASDAQ Small Cap, if they reach $1 per share and have market cap above a certan level. Won't take ALRT much news to reach the $1 level. If they can show they will have a minimum of 100,000 diabetes patients that should get them to the $1 to $3 range.
News from ALRT. FDA clearance a year ago but now appears that all components are ready to go.
News from ALRT. Could be a nice increase today. FDA clearance a year ago but now components seem to be all finished.
Check out the news on ALRT. Could this be the start of price increases---FDA clearance a year ago, but now they have the other compenents ready to go.
good news. check out the link to the photos. Now hope news of a contract get's out by end of Sept.
ALR Technologies Completes Development Phase for Universal Internet-Based Glucose Monitoring System
First-in-Class Data Upload Cable Already Attracting Attention of Frontline Clinicians Nationwide
RICHMOND, VA--(Marketwire -08/28/12)- ALR Technologies Inc. (ALRT) (the "Company"), a health information technology developer, has completed development of its HIPAA-compliant, FDA-cleared Internet-based glucose monitoring system, Health-e-Connect. In
addition to the development of Health-e-Connect, the Company unveiled a first-of-its-kind universal data upload cable that is uniquely able to transfer patient data from most digital glucose meters into one glucose monitoring population management system, Health-e-Connect.
ALR Technologies is now preparing for commercial production of the universal cable in conjunction with the national sales and distribution of their Health-e-Connect System.
Compatible with most digital glucose meters produced by the nation's top five manufacturers -- Abbott, Bayer, LifeScan (Johnson & Johnson), Nipro and Roche -- the Health-e-Connect system and universal data cable have already attracted the attention of frontline clinicians attending several recent national diabetes conventions. Endocrinologists, primary care physicians, and diabetes educators immediately saw the benefit of replacing multiple software platforms and data cables with one universal glucose monitoring platform and data upload cable.
"The universal cable is one of the cornerstones of the ALR Technologies system and we feel it gives us another competitive edge over others in the diabetes management space," says Sidney Chan, Chief Executive Officer and Chairman of ALR Technologies. "Managing multiple software platforms is not practical or cost-effective for providers, and it's not good for patients. Health-e-Connect eliminates the inefficiencies created by multiple platforms, giving providers more time to spend on direct patient care. It also gives providers the tools necessary to effectively manage entire patient populations, which is where the real opportunities lie in leveraging technology to coordinate care, improve patient outcomes, contain complications and reduce costs for widespread chronic diseases like diabetes."
Images comparing the universal cable with current clinical practice can be viewed at: www.alrt.com/assets/images/Cable_Comparison.pdf
Taglich investment bank analyst provides update on ALRT. New short term target price is $.40 a share. I think this price will come about much sooner than the analyst, but they have to be very cautious/conservative.
Interesting question. Because their system provides documentation and assists in lowering cost of care for diabetes patients I don't think any healthcare bill or changes in healthcare will impact their timing or their likely success. Providing better health outcomes while lowering cost surely will be a priority for health plans.
well stated cdietz. I concur, appears they are intching to tell us exactly what is developing so it must be a BIG ONE. Quarterly report doesn't bother me. It's the same language as usual. Once they start commercial business all should change rather fast. I'm looking for $3 plus.
Cdietz; your take on the news(same as the webinar with no contracts, etc) must be what some shareholders saw given the selling today. Created good buying opportunity. This ALRT system looks to fit perfect for the needs of healthcare today. Brings health benefits and lowers cost.
agreed, it shouldn't take much (one good contract) for this stock to depart the penny tag and move on up
I see it as all good. Note the reference to HIPAA. I expect they were finalizing their system to meet the HIPAA requirements for transmission of medical information. Must be absolutely secure. And this quote from the CEO speaks volumes!! "We have formulated a unique business model which, if successfully introduced, will facilitate ALR Technologies emerging as the dominant player in diabetes management. Given the parties involved and the proprietary nature of the business model, there is a high degree of sensitivity with regards to timing and disclosure." Note the reference to DOMINATNT PLAYER IN DIABETES MANAGEMENT. Companies don't just say things like that without high degree of conviction. And the comment about the parties involved in partnership discussions and the proprietary and sensitive nature, suggests it's likely with A MEGA LARGE CORPORATION. That's how I read it.